Stem cell treatment fails clinical trial

According to the New York Times, the a treatment in clinical trials from Osiris, which used adult stem cells was no more effective, over all, than a placebo in treating a life-threatening complication of bone marrow transplantation, though certain patients seemed to be helped.

This is a major set back for the company producing the stem-cell treatment, as they hoped that it would be the first stem cell product approved by the FDA. Read the full article here.